Zhifei Longcom Biologic Pharmacy

Anhui Zhifei Longcom Biologic Pharmacy is a leading Chinese biotechnology company focused on the development and commercialization of human vaccines. A core subsidiary of Chongqing Zhifei Biological Products, the company is best known for its recombinant protein COVID-19 vaccine, Zifivax, developed in collaboration with the Chinese Academy of Sciences. Its product portfolio also features the innovative Mycobacterium tuberculosis vaccine (AEC/BC02) and several pediatric combination vaccines. With extensive GMP-certified manufacturing capabilities in Hefei, the company plays a critical role in China's public health infrastructure and global infectious disease prevention.